Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.058 | 0.7 |
mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |